The 48 rating InvestorsObserver gives to Aslan Pharmaceuticals Ltd (ASLN) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 78 percent of stocks in the Biotechnology industry, ASLN’s 48 overall rating means the stock scores better than 48 percent of all stocks.
ASLN has an Overall Score of 48. Find out what this means to you and get the rest of the rankings on ASLN!